Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.
| Brand name | ENTECAVIR |
| Generic name | ENTECAVIR |
| Active ingredient(s) | ENTECAVIR ANHYDROUS |
| Distributed by / for | Camber Pharmaceuticals, Inc., Piscataway, NJ 08854. By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India |
| NDC | 31722-833-30 |
| Full product label | Entecavir Tablets 0.5 mg, 30 tablets per container, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854. By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India. NDC 31722-833-30 |
| Recalling firm | Hetero USA Inc |
| Distribution | NJ |
| Quantity | 5664 bottles |
| Recall initiated | 2017-07-20 |
| Report date | 2017-08-23 |
| Recall completed | 2019-02-27 |
| Recall number | D-1095-2017 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Piscataway NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗